Jazz Pharmaceuticals JAZZ Tax on Share Settlement
Tax on Share Settlement at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's tax on share settlement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's tax on share settlement?
- Jazz Pharmaceuticals (JAZZ) reported tax on share settlement of $103.6M in Q1 2026.
- How has Jazz Pharmaceuticals's tax on share settlement changed year-over-year?
- Jazz Pharmaceuticals's tax on share settlement increased by 54.2% year-over-year, from $67.2M to $103.6M.
- What is the long-term trend for Jazz Pharmaceuticals's tax on share settlement?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's tax on share settlement has grown at a 20.6% compound annual growth rate (CAGR), from $35.6M to $75.22M.
- What does tax on share settlement mean?
- Cash paid for taxes on employee stock awards.
- How do you interpret tax on share settlement?
- Higher payments correlate with higher levels of equity-based compensation and employee stock vesting activity.
- How does tax on share settlement compare across companies?
- Standard for companies with significant stock-based compensation plans.